Celyad to address US institutional investors in January at J.P. Morgan Healthcare Conference

Celyad to address US institutional investors in January at J.P. Morgan Healthcare Conference

Celyad announces the appointment of Pierre Brynaert as Chief Human Resources Officer

Celyad announces the appointment of Pierre Brynaert as Chief Human Resources Officer

Celyad announces third quarter 2015 business update

Celyad announces third quarter 2015 business update

Celyad CEO Invited to Present at 2015 CAR-T Summit in Massachusetts.

Celyad CEO Invited to Present at 2015 CAR-T Summit in Massachusetts.

List of key investors events Celyad will attend in the coming months

List of key investors events Celyad will attend in the coming months

Advanced Therapies: forthcoming improvements to Belgium’s regulatory framework

Advanced Therapies: forthcoming improvements to Belgium’s regulatory framework

Celyad CEO Invited to Present at 2015 Stem Cell Meeting on the Mesa

Celyad CEO Invited to Present at 2015 Stem Cell Meeting on the Mesa

Celyad participating in Large and Midcap Event in Paris

Celyad participating in Large and Midcap Event in Paris

Celyad CMO to Chair the National Heart, Lung and Blood Institute Special Emphasis Panel

Celyad CMO to Chair the National Heart, Lung and Blood Institute Special Emphasis Panel

Celyad announces the appointment of Dr. Frederic Lehmann as Vice President Immuno-Oncology

Celyad announces the appointment of Dr. Frederic Lehmann as Vice President Immuno-Oncology

Celyad announces the appointment of Dr. Debasish Roychowdhury as independent director

Celyad announces the appointment of Dr. Debasish Roychowdhury as independent director

Celyad announces commercial license agreement for C-Cure® in Greater China

Celyad announces commercial license agreement for C-Cure® in Greater China